全文获取类型
收费全文 | 87845篇 |
免费 | 6371篇 |
国内免费 | 2897篇 |
专业分类
耳鼻咽喉 | 246篇 |
儿科学 | 1188篇 |
妇产科学 | 997篇 |
基础医学 | 7108篇 |
口腔科学 | 1777篇 |
临床医学 | 6761篇 |
内科学 | 15581篇 |
皮肤病学 | 1085篇 |
神经病学 | 7129篇 |
特种医学 | 1246篇 |
外国民族医学 | 11篇 |
外科学 | 5512篇 |
综合类 | 9359篇 |
现状与发展 | 18篇 |
一般理论 | 3篇 |
预防医学 | 5525篇 |
眼科学 | 846篇 |
药学 | 24702篇 |
23篇 | |
中国医学 | 3264篇 |
肿瘤学 | 4732篇 |
出版年
2024年 | 133篇 |
2023年 | 1251篇 |
2022年 | 2154篇 |
2021年 | 3159篇 |
2020年 | 2741篇 |
2019年 | 2649篇 |
2018年 | 2805篇 |
2017年 | 2795篇 |
2016年 | 2569篇 |
2015年 | 2769篇 |
2014年 | 5005篇 |
2013年 | 8002篇 |
2012年 | 4574篇 |
2011年 | 5113篇 |
2010年 | 4221篇 |
2009年 | 3894篇 |
2008年 | 4077篇 |
2007年 | 3889篇 |
2006年 | 3576篇 |
2005年 | 3273篇 |
2004年 | 2860篇 |
2003年 | 2646篇 |
2002年 | 2186篇 |
2001年 | 1995篇 |
2000年 | 1743篇 |
1999年 | 1525篇 |
1998年 | 1420篇 |
1997年 | 1441篇 |
1996年 | 1295篇 |
1995年 | 1138篇 |
1994年 | 998篇 |
1993年 | 891篇 |
1992年 | 873篇 |
1991年 | 786篇 |
1990年 | 691篇 |
1989年 | 622篇 |
1988年 | 591篇 |
1987年 | 451篇 |
1986年 | 488篇 |
1985年 | 679篇 |
1984年 | 579篇 |
1983年 | 406篇 |
1982年 | 424篇 |
1981年 | 360篇 |
1980年 | 294篇 |
1979年 | 231篇 |
1978年 | 207篇 |
1977年 | 159篇 |
1976年 | 142篇 |
1975年 | 100篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
6.
Her-Shyong Shiah Nai-Jung Chiang Chia-Chi Lin Chia-Jui Yen Hui-Jen Tsai Shang-Yin Wu Wu-Chou Su Kwang-Yu Chang Ching-Chiung Wang Jang-Yang Chang Li-Tzong Chen 《The oncologist》2021,26(4):e567-e579
Lessons Learned
- SCB01A is a novel microtubule inhibitor with vascular disrupting activity.
- This first‐in‐human study demonstrated SCB01A safety, pharmacokinetics, and preliminary antitumor activity.
- SCB01A is safe and well tolerated in patients with advanced solid malignancies with manageable neurotoxicity.
7.
Anela Stanic Denis Rybin Francis Cannata Carole Hohl Jennifer Brody Jessie Gaeta 《AIDS care》2021,33(1):1-9
ABSTRACT The lack of stable housing can impair access and continuity of care for patients living with human immunodeficiency virus (HIV). This study investigated the relationship between housing status assessed at multiple time points and several core HIV-related outcomes within the same group of HIV patients experiencing homelessness. Patients with consistently stable housing (CSH) during the year were compared to patients who lacked CSH (non-CSH group). The study outcomes included HIV viral load (VL), CD4 counts, and health care utilization. Multivariable and propensity weighted analyses were used to assess outcomes adjusting for potential group differences. Of 208 patients, 88 (42%) had CSH and 120 (58%) were non-CSH. Patients with CSH had significantly higher proportion of VL suppression and higher mean CD4 counts. The frequency of nurse visits in the CSH group was less than a half of that in the non-CSH group. Patients with CSH were less likely to be admitted to the medical respite facility, and if admitted, their length of stay was about a half of that for the non-CSH group. Our study findings show that patients with CSH had significantly better HIV virologic control and immune status as well as improved health care utilization. 相似文献
8.
9.
《Cancer cell》2021,39(9):1214-1226.e10
- Download : Download high-res image (204KB)
- Download : Download full-size image
10.
Major depressive disorder and other neuropsychiatric disorders are often managed with long-term use of antidepressant medication. Fluoxetine, an SSRI antidepressant, is widely used as a first-line treatment for neuropsychiatric disorders. However, fluoxetine has also been shown to increase the risk of metabolic diseases such as non-alcoholic fatty liver disease. Fluoxetine has been shown to increase hepatic lipid accumulation in vivo and in vitro. In addition, fluoxetine has been shown to alter the production of prostaglandins which have also been implicated in the development of non-alcoholic fatty liver disease. The goal of this study was to assess the effect of fluoxetine exposure on the prostaglandin biosynthetic pathway and lipid accumulation in a hepatic cell line (H4-II-E-C3 cells). Fluoxetine treatment increased mRNA expression of prostaglandin biosynthetic enzymes (Ptgs1, Ptgs2, and Ptgds), PPAR gamma (Pparg), and PPAR gamma downstream targets involved in fatty acid uptake (Cd36, Fatp2, and Fatp5) as well as production of 15-deoxy-Δ12,14PGJ2 a PPAR gamma ligand. The effects of fluoxetine to induce lipid accumulation were attenuated with a PTGS1 specific inhibitor (SC-560), whereas inhibition of PTGS2 had no effect. Moreover, SC-560 attenuated 15-deoxy-Δ12,14PGJ2 production and expression of PPAR gamma downstream target genes. Taken together these results suggest that fluoxetine-induced lipid abnormalities appear to be mediated via PTGS1 and its downstream product 15d-PGJ2 and suggest a novel therapeutic target to prevent some of the adverse effects of fluoxetine treatment. 相似文献